Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 20Recruiting 12Unknown 5Withdrawn 2Terminated 1Suspended 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 219Gastrointestinal 15Breast 13Gynecologic 8Thoracic 4Head & Neck 3Dermatologic 2CNS 2Sarcoma 1Plasma cell 1Other 1NET 1Endocrine 1

Conditions

Thyroid Cancer, Papillary 15Neuroendocrine Tumors 13Carcinoma, Neuroendocrine 10Pituitary Neoplasms 8Thyroid Neoplasms 6Thyroid Carcinoma, Anaplastic 5Pheochromocytoma 5Neoplasms 4Paraganglioma 3Multiple Endocrine Neoplasia Type 1 3Small Cell Lung Carcinoma 2Recurrence 2Rectal Neuroendocrine Tumor 2Pituitary ACTH Hypersecretion 2Neoplasm Metastasis 2Melanoma 2Cushing Syndrome 2Adenocarcinoma, Follicular 2Acromegaly 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Thyroid cancer, medullary 1Testicular Neoplasms 1Serotonin Syndrome 1Sarcoma 1SDH-Related Familial Paraganglioma 1Rectal Neuroendocrine Tumors 1Rectal Neoplasms 1Prostatitis 1Prostatic Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Prostatic Neoplasms × Endocrine × Clear all
NCT04889742 2023-12-26

HETERERO

Charite University, Berlin, Germany

Phase 2 Not yet recruiting
110 enrolled
EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡